CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-19 | Gayer Charles K Chief Commercial Officer | Grant or award · Emp. Stock Option (Right to Buy) | +260,950 | 260,950 | ||
| 2024-12-19 | Thackray Helen M. Chief R&D Officer | Grant or award | +125,950 | 390,939 | ||
| 2024-12-19 | Thackray Helen M. Chief R&D Officer | Shares withheld for taxes | −6,096 | $7.39 | $45K | 384,843 |
| 2024-12-19 | Thackray Helen M. Chief R&D Officer | Grant or award · Emp. Stock Option (Right to Buy) | +260,950 | 260,950 | ||
| 2024-12-19 | Doyle Anthony Chief Financial Officer | Grant or award | +120,700 | 380,328 | ||
| 2024-12-19 | Doyle Anthony Chief Financial Officer | Shares withheld for taxes | −2,461 | $7.39 | $18K | 377,867 |
| 2024-12-19 | Doyle Anthony Chief Financial Officer | Grant or award · Emp. Stock Option (Right to Buy) | +250,100 | 250,100 | ||
| 2024-12-19 | Barnes Alane P Chief Legal Officer | Grant or award | +120,700 | 415,190 | ||
| 2024-12-19 | Barnes Alane P Chief Legal Officer | Shares withheld for taxes | −2,461 | $7.39 | $18K | 412,729 |
| 2024-12-19 | Barnes Alane P Chief Legal Officer | Grant or award · Emp. Stock Option (Right to Buy) | +250,100 | 250,100 | ||
| 2024-12-19 | Stonehouse Jon P President & CEO | Grant or award | +362,100 | 1,463,119 | ||
| 2024-12-19 | Stonehouse Jon P President & CEO | Shares withheld for taxes | −14,010 | $7.39 | $104K | 1,449,109 |
| 2024-12-19 | Stonehouse Jon P President & CEO | Grant or award · Emp. Stock Option (Right to Buy) | +750,250 | 750,250 | ||
| 2024-12-14 | Gayer Charles K Chief Commercial Officer | Shares withheld for taxes | −8,251 | $7.53 | $62K | 300,057 |
| 2024-12-14 | Stonehouse Jon P President & CEO | Shares withheld for taxes | −27,525 | $7.53 | $207K | 1,101,019 |
| 2024-12-14 | Barnes Alane P Chief Legal Officer | Shares withheld for taxes | −8,613 | $7.53 | $65K | 294,490 |
| 2024-12-14 | Doyle Anthony Chief Financial Officer | Shares withheld for taxes | −7,890 | $7.53 | $59K | 259,628 |
| 2024-12-14 | Thackray Helen M. Chief R&D Officer | Shares withheld for taxes | −7,150 | $7.53 | $54K | 264,989 |
| 2024-12-13 | Hutson Nancy J Director | Sale 10b5-1 | −7,000 | $7.54 | $53K | 86,638 |
| 2024-11-29 | MILANO VINCENT Director | Grant or award | +750 | $7.50 | $6K | 76,084 |
Page 7 of 18 · 357 trades